On April 28, 2017, a federal court in Massachusetts sanctioned a whistleblower’s attorneys by dismissing a case that the judge ruled only survived dismissal because of information the attorneys sourced in an unethical manner. See Leysock v. Forest Laboratories, Inc., No. 12-11354-FDS (D. Mass. Apr. 28, 2017), appeal docketed, No. 17-1538 (1st Cir. May 25, 2017). The whistleblower alleged that the pharmaceutical company Forest Pharmaceuticals Inc. improperly promoted the drug Namenda for off-label use. The court found that the whistleblower’s counsel hired a medical researcher to interview doctors about issues related to that off-label use without disclosing that the interviews were for a lawsuit rather than for medical research.